Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial

Conclusions Compared with TF TAVR, TA TAVR is associated with a disproportionate risk of cardiac mortality in patients with LV dysfunction and with delayed and less robust improvement in LV function and overall functional status. Caution is warranted when considering TA access for structural heart disease interventions, particularly in patients with LV dysfunction. (Placement of Aortic Transcatheter Valves [PARTNER]; NCT00530894)

http://www.interventions.onlinejacc.org/cgi/content/short/10/23/2414?rss=1

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Elmariah, S., Fearon, W. F., Inglessis, I., Vlahakes, G. J., Lindman, B. R., Alu, M. C., Crowley, A., Kodali, S., Leon, M. B., Svensson, L., Pibarot, P., Hahn, R. T., Thourani, V. H., Palacios, I. F., Miller, D. C., Douglas, P. S., Passeri, J. J., on beha Tags: Structural Source Type: research